Summary
Transfer of basic research results to clinical application with generation of novel treatment options for neurodegenerative diseases is an important issue but appeared to be extremely difficult in the past. This introductory chapter addresses these difficulties embracing health care expenses, basic research as well as therapeutic options in the hospital with their limitations and possibilities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87(2): 171.
Andersen JK. (2001) Does neuronal loss in Parkinson’s disease involve programmed cell death? Bioessays 23(7):640–6.
Antuono P, Beyer J. (1999) The burden of dementia. A medical and research perspective. Theor Med Bioeth.20(l):3–13.
Baekelandt V, De Strooper B, Nuttin B, Debyser Z. (2000) Gene therapeutic strategies for neurodegenerative diseases. Curr Opin Mol Ther. 2(5):540–54.
Barde YA. (1989) Trophic factors and neuronal survival. Neuron. 2(6): 1525–34.
Becker-Hapak M, McAllister SS, Dowdy SF. (2001) TAT-mediated protein transduction into mammalian cells. Methods. 24(3):247–56.
Choi DW. (1992) Excitotoxic cell death. J Neurobiol. 23(9):1261–76.
Dirnagl U, Iadecola C., Moskowitz MA. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22(9):391–7.
Estibeiro P, Godfray J. (2001) Antisense as a neuroscience tool and therapeutic agent. Trends Neurosci. 24(11 Suppl):S56–62.
Ford KG, Souberbielle BE, Darling D, Farzaneh F. (2001) Protein transduction: an alternative to genetic intervention? Gene Ther. 8(1): 1–4.
Gortelmeyer R, Erbler H. (1992) Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study. Arzneimittelforschung. 42(7):904–13.
Kroemer G, Reed JC. (2000) Mitochondrial control of cell death. Nat Med. 6(5):513–9.
Lindblad K, Schalling M. (1999) Expanded repeat sequences and disease. Semin Neurol. 19(3):289–99.
Oertel WH, Bandmann O. (1999) Multiple system atrophy. J Neural Transm Suppl. 56:155–64.
Payne KA, Huybrechts KF, Caro J, Craig Green TJ, Klittich WS. (2002) Long Term Cost-of-Illness in Stroke: An International Review. Pharmacoeconomics. 20(12):813–25.
Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C., Kang X, et al. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80(1): 167–78.
Sanchez Mejia RO, Friedlander RM. (2001) Caspases in Huntington’s disease. Neuroscientist. 7(6):480–9
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Kermer, P., Bähr, M. (2004). General Remarks on the Bridging Between Basic Research and Clinics. In: Herdegen, T., Delgado-García, J. (eds) Brain Damage and Repair. Springer, Dordrecht. https://doi.org/10.1007/1-4020-2541-6_32
Download citation
DOI: https://doi.org/10.1007/1-4020-2541-6_32
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6538-4
Online ISBN: 978-1-4020-2541-9
eBook Packages: Springer Book Archive